Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122178) titled 'Multimodal AI-assisted Surgical Decision and Prognosis Evaluation for Clear Cell Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus' on April 9.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Medical Center of the General Hospital of the People's Liberation Army of China
Condition:
Clear Cell Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus
Intervention:
Gold Standard:Assessment of IVC Wall Invasion: Histopathological confirmation of tumor invasion into the inferior vena cava wall
Criteria for Rapid Thrombus Growth: The cranial extensi...